Showing results (271-280 of 338) with videos related to
Sort By:
Pageof 34
International Journal of Molecular Sciences|May 14, 2022
Plasma Aldo-Keto Reductase Family 1 Member B10 as a Biomarker Performs Well in the Diagnosis of Nonalcoholic Steatohepatitis and FibrosisAron Park, Seung Joon Choi, Sungjin Park, et al.Journal of Clinical Pathology|November 3, 2006
Epidermal growth factor receptor status in anaplastic thyroid carcinomaDae Ho Lee, Geon Kook Lee, Sun-Young Kong, et al.Molecular Metabolism|November 28, 2021
A novel role of CRTC2 in promoting nonalcoholic fatty liver diseaseHye-Sook Han, Sang Gyune Kim, Young Seok Kim, et al.Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancerByoung Chul Cho, Kiyotaka Yoh, Ruth Perets, et al.International Journal of Cancer|August 9, 2011
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapyHo-Young Yhim, Jin Seok Kim, Hye Jin Kang, et al.Acta Haematologica|December 20, 2011
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.Diabetes Care|June 11, 2014
Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patientsSang Ah Lee, Suk Ju Cho, Myung Ho Jeong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2023
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 TrialMartin Reck, Fabrice Barlesi, James Chih-Hsin Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lungJi-Youn Han, Keunchil Park, Sang-We Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2018
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung CancerYi-Long Wu, Li Zhang, Dong-Wan Kim, et al.Pageof 34